» Authors » Vikram Haridas

Vikram Haridas

Explore the profile of Vikram Haridas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Haridas V, Hoskatti C, Choukimath S, Haridas K, Patil P, Pavan K, et al.
Int J Rheum Dis . 2024 Jul; 27(8):e15283. PMID: 39078086
No abstract available.
2.
Chebbi P, Shobha V, Rao V, Haridas V, Janardana R, Pinto B, et al.
BMC Rheumatol . 2023 Jul; 7(1):22. PMID: 37496101
Introduction: We assessed the risk factors and outcome of COVID-19 in patients with autoimmune rheumatic diseases(AIRD) who contracted infection while on background treatment with tofacitinib. Methods: This is a non-interventional,...
3.
Patil A, Shobha V, Shenoy P, S C, Kumar S, Daware M, et al.
Lupus . 2023 Feb; 32(4):560-564. PMID: 36731873
Introduction: Patients with SLE (systemic lupus erythematosus) have a higher risk of infection due to dysregulated immune system as well as long-term use of immunosuppressants (IS). This could influence the...
4.
Patil A, Chanakya K, Shenoy P, Chandrashekara S, Haridas V, Kumar S, et al.
BMC Rheumatol . 2022 Jun; 6(1):32. PMID: 35698182
Background: We conducted this study to identify the influence of prolonged use of hydroxychloroquine (HCQ), glucocorticoids and other immunosuppressants (IS) on occurrence and outcome of COVID-19 in patients with autoimmune...
5.
K N, Patil P, Bhandary S, Haridas V, Kumari N S, E S, et al.
F1000Res . 2021 May; 10:273. PMID: 34046165
Coronavirus disease 2019 (CoVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 has affected more than 100 million lives. Severe CoVID-19 infection may lead to acute respiratory distress syndrome and...
6.
Janardana R, Haridas V, Priya V, Bhat V, Singh Y, Rao V, et al.
Lupus . 2020 Aug; 29(11):1397-1403. PMID: 32741300
Introduction: Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research priority. The aims of this study were to investigate (a) the maternal and fetal outcomes...
7.
Manoharan Y, Haridas V, Vasanthakumar K, Muthu S, Thavoorullah F, Shetty P
Indian J Clin Biochem . 2020 Jul; 35(3):373-375. PMID: 32641876
No abstract available.
8.
Chandrashekara S, Shobha V, Dharmanand B, Jois R, Kumar S, Mahendranath K, et al.
Int J Rheum Dis . 2019 Apr; 22(7):1216-1225. PMID: 30977300
Aim: The use of healthcare resources by rheumatoid arthritis (RA) patients can be related to the presence of disease, comorbid conditions, use of steroids, and the combined use of immunosuppressants....
9.
Haridas V, Haridas K
J Assoc Physicians India . 2018 Nov; 66(5):14-6. PMID: 30477056
Aim: To evaluate the prevalence of anti-thyroid antibodies in a cohort of rheumatoid arthritis (RA) patients from south India and their clinical use. Methods: A cross-sectional epidemiological study was conducted...
10.
Haridas V, Shetty P, Sarathkumar E, Bargale A, Vishwanatha J, Patil V, et al.
Mol Biol Rep . 2018 Nov; 46(1):83-95. PMID: 30426384
Annexin A2 has been implicated in several immune modulated diseases including Rheumatoid arthritis (RA) pannus formation. The most relied treatment option for RA pathogenesis is glucocorticoids. Glucocorticoids regulate the synthesis,...